Acquired Resistance of ER-Positive Breast Cancer to Endocrine Treatment Confers an Adaptive Sensitivity to TRAIL through Posttranslational Downregulation of c-FLIP

PIGGOTT, L., SILVA, A., ROBINSON, T., SANTIAGO-GOMEZ, A., SIMOES, B. M., BECKER, M., FICHTNER, I., ANDĚRA, L., YOUNG, P., MORRIS, C., BARRETT-LEE, P., ALCHAMI, F., PIVA, M., VIVANCO, M. D., CLARKE, R. B., GEE, J., CLARKSON, R. Acquired Resistance of ER-Positive Breast Cancer to Endocrine Treatment Confers an Adaptive Sensitivity to TRAIL through Posttranslational Downregulation of c-FLIP. Clinical Cancer Research. 2018, 24(10), 2452-2463. ISSN 1078-0432. E-ISSN 1557-3265. Available: doi: 10.1158/1078-0432.CCR-17-1381